India, Sept. 30 -- ADM, a global leader in innovative solutions from nature, today announced that Fibersol, a premier line of soluble prebiotic fibers, has received approval from the Therapeutic Goods Administration (TGA), part of the Australian Department of Health, for use as an active ingredient in biologicals, listed medicines, and prescription medicines. The approval expands Fibersols role beyond conventional food and beverage applications into dietary supplements and other regulated health product categories.
Securing TGA approval for Fibersol marks a significant development for ADM, said Helen Hu, president of health & wellness APAC at ADM. It allows our customers to highlight Fibersols clinically supported health benefits on packaging, providing clear value in a category where consumer trust is essential. In todays dynamic health and wellness market, regulatory approvals are more than a requirement; they are a mark of credibility. With this approval, ADM continues to deliver science-backed solutions that give brands a competitive edge and consumers greater confidence in their choices.
Backed by more than 100 scientific publications, Fibersol has been extensively researched, demonstrating its potential across a wide range of health indications. Clinically documented results show that Fibersol:
Promotes the growth of beneficial gut bacteria
Supports a healthy gut microbiota and overall digestive health
Nourishes intestinal flora and maintains a balanced intestinal environment
May delay hunger and support normal production of GLP-1 and peptide
Consumption of Fibersol-2 is associated with a reduction in the uptake of sugars from dietary carbohydrates and in the absorption of dietary triglycerides
In addition to its clinically supported benefits, Fibersol is well-tolerated and versatile[6], with stability observed under heat, acid, shear, and freeze/thaw conditions. Its neutral taste profile makes it easy to incorporate across foods, beverages, and dietary supplements, enabling brands to deliver enjoyable, gut-friendly products without compromising on taste or texture.
The prebiotics market in Australia is projected to grow at a CAGR of 17.6% between 2024 and 2030[7], driven by rising consumer focus on digestive health. Nearly 40% of Australian consumers have taken steps to improve their digestive health in the past year, of which more than one-third (39%) are choosing supplements and vitamins to support this goal[8], highlighting a shift toward targeted, science-backed solutions.
This growing interest in digestive health aligns with the expanding role of prebiotic fibers in supplements and functional products. ADMs latest approval adds to its portfolio of TGA-recognized ingredients, following DE111 in 2024, and underscores Fibersols strong clinical foundation.
Published by HT Digital Content Services with permission from FoodTechBiz.